Evidence map›Paper›PMID 40593564›Full record

ArticleNature communications2025

Charting γ-secretase substrates by explainable AI.

Stephan Breimann, Frits Kamp, Gabriele Basset, Claudia Abou-Ajram, Gökhan Güner, Kanta Yanagida, Masayasu Okochi, Stephan A Müller, Stefan F Lichtenthaler, Dieter Langosch and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephan Breimann *Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, München, Germany.ORCID http://orcid.org/0000-0002-0305-3373
Frits Kamp *Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, München, Germany.ORCID http://orcid.org/0000-0001-8382-6884
Gabriele BassetBiomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, München, Germany.
Claudia Abou-AjramBiomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, München, Germany.
Gökhan GünerGerman Center for Neurodegenerative Diseases (DZNE), DZNE Munich, München, Germany.
Kanta YanagidaDepartment of Pharmacotherapeutics II, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Masayasu OkochiNeuropsychiatry, Department of Integrated Medicine, Division of Internal Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Stephan A MüllerGerman Center for Neurodegenerative Diseases (DZNE), DZNE Munich, München, Germany.ORCID http://orcid.org/0000-0003-3414-307X
Stefan F LichtenthalerGerman Center for Neurodegenerative Diseases (DZNE), DZNE Munich, München, Germany.ORCID http://orcid.org/0000-0003-2211-2575
Dieter LangoschBiopolymer Chemistry, TUM, Freising, Germany.ORCID http://orcid.org/0000-0002-8098-0015
Dmitrij FrishmanDepartment of Bioinformatics, Technical University of Munich (TUM), Freising, Germany. dmitrij.frishman@tum.de.
Harald SteinerBiomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, LMU Munich, München, Germany. harald.steiner@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-3935-0318

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) ID 263531414
6 · The paper itself

Abstract

Proteases recognize substrates by decoding sequence information-an essential cellular process elusive when recognition motifs are absent. Here, we unravel this problem for γ-secretase, an intramembrane-cleaving protease associated with Alzheimer's disease and cancer, by developing Comparative Physicochemical Profiling (CPP), a sequence-based algorithm for identifying interpretable physicochemical features. We show that CPP deciphers a γ-secretase substrate signature with single-residue resolution, which can explain the conformational transitions observed in substrates upon γ-secretase binding. Using machine learning, we predict the entire human γ-secretase substrate scope, revealing numerous previously unknown substrates. Our approach outperforms state-of-the-art protein language models, improving prediction accuracy from 60% to 90%, and achieves an 88% success rate in experimental validation. Building on these advancements, we identify pathways and diseases not linked before to γ-secretase. Generally, CPP decodes physicochemical signatures-a concept that extends beyond sequence motifs. We anticipate that our approach will be broadly applicable to diverse molecular recognition processes.

Indexed as

Amyloid Precursor Protein SecretasesAlgorithmsAlzheimer DiseaseHumansMachine LearningProtein BindingSubstrate SpecificityAmyloid Precursor Protein Secretases

Identifiers

PMID40593564
PMCPMC12219630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.